Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.
Background: Post-transplantation lymphoproliferative disorders are serious complications of organ transplantation which treatment is not yet standardized. Objective: To describe the clinical response, overall and graft survival of patients in our center with this complication after kidney transplant...
Uloženo v:
| Vydáno v: | Colombia Médica |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Universidad del Valle
2016
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=28349362004 https://www.redalyc.org/journal/283/28349362004/ https://www.redalyc.org/journal/283/28349362004/html/ https://www.redalyc.org/journal/283/28349362004/28349362004.epub https://www.redalyc.org/journal/283/28349362004/movil |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
